🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

23 recruiting trials

for Breast Neoplasm Malignant Primary

Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors NCT04771520Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Avapritinib Cancer Genetic Testing in Ethnic Populations NCT04475640NA2 sites📍 Scottsdale📍 Jacksonville Mayo Clinic · Tests: Biospecimen Collection, Genetic Testing Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer NCT00477100n/a10 sites📍 Gilbert📍 La Jolla📍 Greeley M.D. Anderson Cancer Center · Tests: Biospecimen Collection, Interview, Medical Chart Review, Questionnaire Administration Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF NCT03604315Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Computed Tomography, Computed Tomography, Fludeoxyglucose F-18, Fluorine F 18 Fluorthanatrace, Positron Emission Tomogr… Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment NCT02253251n/a1 site📍 Los Angeles MiraKind · Tests: KRAS-variant and microRNA binding site mutation testing Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity NCT04273061Phase 22 sites📍 Vancouver📍 Toronto British Columbia Cancer Agency · Tests: Atezolizumab The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas NCT07285044Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Cancer Therapeutic Procedure, Cancer Therapeutic Procedure, Questionnaire Administration Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab Ontario-wide Cancer TArgeted Nucleic Acid Evaluation NCT02906943n/a7 sites📍 Hamilton📍 Kingston📍 London University Health Network, Toronto Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK) NCT07524114n/a1 site📍 Toronto University Health Network, Toronto Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax NCT05092373Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel, Tumor Treating Fields Therapy TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography NCT06310330NA1 site📍 Trondheim Norwegian University of Science and Technology · Tests: Comprehensive echocardiographic follow-up, Simplified echocardiographic follow-up SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774n/a68 sites📍 Birmingham📍 Mobile📍 Scottsdale Massive Bio, Inc. · Tests: Clinical Trial Matching Genomic Investigation of Unusual Responders NCT03740503n/a1 site📍 Toronto University Health Network, Toronto A Beta-only IL-2 ImmunoTherapY Study NCT05086692Phase 1, Phase 228 sites📍 San Diego📍 San Francisco📍 Santa Monica Medicenna Therapeutics, Inc. · Tests: MDNA11, Pembrolizumab (KEYTRUDA®) Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM) NCT05465031Phase 44 sites📍 Opole📍 Gliwice📍 Zabrze Silesian Centre for Heart Diseases · Tests: Sacubitril-valsartan, Placebo At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer NCT05969860Phase 22 sites📍 Jacksonville📍 Grand Forks Mayo Clinic · Tests: Clinical Encounter, Home Health Encounter, Quality-of-Life Assessment, Questionnaire Administration Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial NCT05564377Phase 2484 sites📍 Birmingham📍 Mobile📍 Anchorage National Cancer Institute (NCI) · Tests: Alpelisib, Binimetinib, Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration Preoperative vs. Pathologic Size in Breast Cancer: A Prospective Study NCT06505577n/a1 site📍 Incheon Incheon St.Mary's Hospital · Tests: No additional intervention Intravital Microscopy in Human Solid Tumors NCT03823144NA1 site📍 Jacksonville Mayo Clinic · Tests: Diagnostic Microscopy, Fluorescein Sodium Injection SBRT in Early Breast Cancer in Elderly Women NCT05071105NA1 site📍 Rome University of Rome Tor Vergata · Tests: Stereotactic Body Radiation Therapy Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors NCT07410494Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EB-SELECT Single-Target CAR-NK Cells, Dual-Target Antigen-Selected CAR-NK
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy